People · Operator
Named in public records as an officer, director or promoter · active 2013–2026 · Other, Other Technology, Pharmaceuticals, Healthtech, Business Services, Manufacturing
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| NuoDB, Inc. | — | Other | Series B | $88.0M | $507.6M | 2014 |
| EverQuote, Inc. | — | Other Technology | Series B | $52.4M | $255.9M | 2015 |
| Stargazer Pharmaceuticals, Inc. | — | Pharmaceuticals | Series B | $28.5M | $967.8M | 2018 |
| Care Continuity, Inc. | — | Healthtech | Series A | $15.5M | $15.8M | 2023 |
| Applied Process Holdings, LLC | — | Other | Series A | $10.2M | $154.4M | 2014 |
| CoLabs QOF, LLC | — | Other Technology | Seed | $5.5M | $26.2M | 2019 |
| Benefit Harbor, LP | — | Business Services | Series A | $5.0M | $25.4M | 2024 |
| CoLabs Holdings, LLC | — | Other Technology | Pre-Seed | $250K | $10.6M | 2018 |
| CoLabs QOF, LLC | Executive Officer, Promoter | Other Technology | Pre-Seed | $199K | $327K | 2026 |
| Chapman's Cider Co LLC | — | Manufacturing | Pre-Seed | $125K | $1.9M | 2013 |
John Wagner at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Wagner on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Marc Miller | 3 | 4 |
| David Hull | 3 | 4 |
| Katrina Itle | 3 | 3 |
| Wende Hutton | 1 | 16 |
| Nilanjana Bhowmik | 1 | 10 |
| Mitchell Kertzman | 1 | 7 |
| Richard Gaster | 1 | 7 |
| David Blundin | 1 | 7 |
| Gary Morgenthaler | 1 | 7 |
| John Shields | 1 | 6 |
| Greg Gibson | 1 | 6 |
| Martin Edwards | 1 | 5 |
| Sal DeTrane | 1 | 4 |
| Daniel Caruso | 1 | 4 |
| STEVE WIGGINTON | 1 | 4 |
| Jonathan Shapiro | 1 | 4 |
| Richard Johnston | 1 | 4 |
| David Mason | 1 | 4 |
| Sanju Bansal | 1 | 4 |
| Douglas Williams | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.